|
1
|
Wei WI and Sham JS: Nasopharyngeal
carcinoma. Lancet. 365:2041–2054. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Guo P, Huang ZL, Yu P and Li K: Trends in
cancer mortality in China: An update. Ann Oncol. 23:2755–2762.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lo KW, Chung GT and To KF: Acquired
genetic and epigenetic alterations in nasopharyngeal carcinoma.
Nasopharyngeal Carcinoma. Busson P: Springer; New York: pp. 61–81.
2013, View Article : Google Scholar
|
|
5
|
Hildesheim A and Wang CP: Genetic
predisposition factors and nasopharyngeal carcinoma risk: A review
of epidemiological association studies, 2000–2011: Rosetta Stone
for NPC: Genetics, viral infection, and other environmental
factors. Semin Cancer Biol. 22:107–116. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
West RB: Fingerprints of Epstein-Barr
virus in nasopharyngeal carcinoma. Nat Genet. 46:809–810. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Polesel J, Serraino D, Negri E, Barzan L,
Vaccher E, Montella M, Zucchetto A, Garavello W, Franceschi S, La
Vecchia C, et al: Consumption of fruit, vegetables, and other food
groups and the risk of nasopharyngeal carcinoma. Cancer Causes
Control. 24:1157–1165. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yoshizaki T, Ito M, Murono S, Wakisaka N,
Kondo S and Endo K: Current understanding and management of
nasopharyngeal carcinoma. Auris Nasus Larynx. 39:137–144. 2012.
View Article : Google Scholar
|
|
9
|
Bensouda Y, Kaikani W, Ahbeddou N, Rahhali
R, Jabri M, Mrabti H, Boussen H and Errihani H: Treatment for
metastatic nasopharyngeal carcinoma. Eur Ann Otorhinolaryngol Head
Neck Dis. 128:79–85. 2011. View Article : Google Scholar
|
|
10
|
Yu F and Loh KS: Cancer stem cells in
nasopharyngeal carcinoma: Current evidence. JNPC. 1:e62014.
View Article : Google Scholar
|
|
11
|
Zentner GE and Henikoff S: Regulation of
nucleosome dynamics by histone modifications. Nat Struct Mol Biol.
20:259–266. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Waldmann T and Schneider R: Targeting
histone modifications - epigenetics in cancer. Curr Opin Cell Biol.
25:184–189. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Greer EL and Shi Y: Histone methylation: A
dynamic mark in health, disease and inheritance. Nat Rev Genet.
13:343–357. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chung S, Sundar I, Rahman I and Yao H:
Cigarette smoke causes a residue-specific histone methylation and
its cross-talk with histone acetylation in human lung epithelial
cells. Am J Respir Crit Care Med. 185:A34742012.
|
|
15
|
Eram MS, Bustos SP, Lima-Fernandes E,
Siarheyeva A, Senisterra G, Hajian T, Chau I, Duan S, Wu H,
Dombrovski L, et al: Trimethylation of histone H3 lysine 36 by
human methyltransferase PRDM9 protein. J Biol Chem.
289:12177–12188. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tang H, Fang H, Yin E, Brasier AR, Sowers
LC and Zhang K: Multiplexed parallel reaction monitoring targeting
histone modifications on the QExactive mass spectrometer. Anal
Chem. 86:5526–5534. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Di Lorenzo A and Bedford MT: Histone
arginine methylation. FEBS Lett. 585:2024–2031. 2011. View Article : Google Scholar
|
|
18
|
Berrens RV and Reik W: Prmt5: A guardian
of the germline protects future generations. EMBO J. 34:689–690.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kim S, Günesdogan U, Zylicz JJ, Hackett
JA, Cougot D, Bao S, Lee C, Dietmann S, Allen GE, Sengupta R, et
al: PRMT5 protects genomic integrity during global DNA
demethylation in primordial germ cells and preimplantation embryos.
Mol Cell. 56:564–579. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chu Z, Niu B, Zhu H, He X, Bai C, Li G and
Hua J: PRMT5 enhances generation of induced pluripotent stem cells
from dairy goat embryonic fibroblasts via down-regulation of p53.
Cell Prolif. 48:29–38. 2015. View Article : Google Scholar
|
|
21
|
Ibrahim R, Matsubara D, Osman W, Morikawa
T, Goto A, Morita S, Ishikawa S, Aburatani H, Takai D, Nakajima J,
et al: Expression of PRMT5 in lung adenocarcinoma and its
significance in epithelial-mesenchymal transition. Hum Pathol.
45:1397–1405. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang B, Dong S, Zhu R, Hu C, Hou J, Li Y,
Zhao Q, Shao X, Bu Q, Li H, et al: Targeting protein arginine
methyltransferase 5 inhibits colorectal cancer growth by decreasing
arginine methylation of eIF4E and FGFR3. Oncotarget. 6:22799–22811.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li G, Liu Y, Su Z, Ren S, Zhu G, Tian Y
and Qiu Y: MicroRNA-324-3p regulates nasopharyngeal carcinoma
radioresistance by directly targeting WNT2B. Eur J Cancer.
49:2596–2607. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li G, Wang Y, Liu Y, Su Z, Liu C, Ren S,
Deng T, Huang D, Tian Y and Qiu Y: miR-185-3p regulates
nasopharyngeal carcinoma radioresistance by targeting WNT2B in
vitro. Cancer Sci. 105:1560–1568. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chua DT, Nicholls JM, Sham JS and Au GK:
Prognostic value of epidermal growth factor receptor expression in
patients with advanced stage nasopharyngeal carcinoma treated with
induction chemotherapy and radiotherapy. Int J Radiat Oncol Biol
Phys. 59:11–20. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lin DC, Meng X, Hazawa M, Nagata Y, Varela
AM, Xu L, Sato Y, Liu LZ, Ding LW, Sharma A, et al: The genomic
landscape of nasopharyngeal carcinoma. Nat Genet. 46:866–871. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yang F, Qian X-J, Qin W, Deng R, Wu XQ,
Qin J, Feng GK and Zhu XF: Dual phosphoinositide 3-kinase/mammalian
target of rapamycin inhibitor NVP-BEZ235 has a therapeutic
potential and sensitizes cisplatin in nasopharyngeal carcinoma.
PLoS One. 8:e598792013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Pan Y, Zhang Q, Atsaves V, Yang H and
Claret FX: Suppression of Jab1/CSN5 induces radio- and
chemo-sensitivity in nasopharyngeal carcinoma through changes to
the DNA damage and repair pathways. Oncogene. 32:2756–2766. 2013.
View Article : Google Scholar :
|
|
29
|
Agaoglu FY, Dizdar Y, Dogan O, Alatli C,
Ayan I, Savci N, Tas S, Dalay N and Altun M: p53 overexpression in
nasopharyngeal carcinoma. In Vivo. 18:555–560. 2004.PubMed/NCBI
|
|
30
|
Dolcet X, Llobet D, Pallares J and
Matias-Guiu X: NF-kB in development and progression of human
cancer. Virchows Arch. 446:475–482. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Shi D, Guo W, Chen W, Fu L, Wang J, Tian
Y, Xiao X, Kang T, Huang W and Deng W: Nicotine promotes
proliferation of human nasopharyngeal carcinoma cells by regulating
α7AChR, ERK, HIF-1α and VEGF/PEDF signaling. PLoS One.
7:e438982012. View Article : Google Scholar
|
|
32
|
Liu Y, Chen LH, Yuan YW, Li QS, Sun AM and
Guan J: Activation of AKT is associated with metastasis of
nasopharyngeal carcinoma. Tumour Biol. 33:241–245. 2012. View Article : Google Scholar
|
|
33
|
Tai HC, Huang HY, Lee SW, Lin CY, Sheu MJ,
Chang SL, Wu LC, Shiue YL, Wu WR, Lin CM, et al: Associations of
Rsf-1 overexpression with poor therapeutic response and worse
survival in patients with nasopharyngeal carcinoma. J Clin Pathol.
65:248–253. 2012. View Article : Google Scholar
|
|
34
|
Gu Z, Gao S, Zhang F and Wang Z, Ma W,
Davis RE and Wang Z: Protein arginine methyltransferase 5 is
essential for growth of lung cancer cells. Biochem J. 446:235–241.
2012. View Article : Google Scholar : PubMed/NCBI
|
